Dyslipidemia leads to cardiovascular disease (CVD) and it is determined by elevation of plasma concentration of lipoproteins. Diabetes is a chronic disorder and it is controlled by different allopathic and Ayurvedic formulation. The synthetic drugs include sulfonyl ureas, biguanides, metformin HCl, DPP-4 inhibitors etc. The folk medicine is practiced by local people. The people use herbal medicine to control and treat the various types of diseases. In India, tribal people used different types of medicinal plants to control the diabetes. In present study ethanol extracts of Passiflora foetida leaves were evaluated for anti-dyslipidemia activity in dextrose induced diabetic rats. The ethanol extracts of P. foetida were administered at the doses of 100 mg/kg body weight, 250 mg/kg body weight and 500 mg/kg body weight to the dextrose induced diabetic rats. The silver nanoparticles were prepared by the reaction of 1 mM silver nitrate and 5% leaf extract of P.
Introduction
Diabetes is metabolic disorders and whole world is facing the problem of diabetes. Diabetes severely affect the normal routine life of human 1, 2 . WHO stated that the occurrence of diabetes is enhanced by 35%. Presently 150 million people are effected by diabetes and it is assume to be increased by 300 million at the end of 2025 3 . It is emerging as one of the leading causes of end stage renal disease, heart attack, non-traumatic amputation, and blindness, increasing the mortality and morbidity burden on the community.
Diabetes is metabolic disorder and is characterized by hyperglycemia, altered lipids, carbohydrates, and proteins metabolism. Diabetes is a metabolism in which a person has high blood sugar, either because the body does not produce enough insulin, or because cells do not respond to the insulin that is produced. Glucose metabolism disturbances are major factors leading to diabetes 4, 5 . Apart from hyperglycemia, the reactive oxygen species and hyperlipidemia play chief role in occurrence of diabetes 6, 7 . Diabetes produces disturbances in lipid profiles and especially, an increased susceptibility to lipid peroxidation. In the last stages of diabetes, lipid metabolism is affected and seen as hyperlipidemia and hypercholesterolemia which are risk factors in atherosclerosis [6] [7] [8] The dyslipidemia leads to CVD and similarly it provokes the coronary heart disease (CHD). It is documented that the mortality of CHD in the developed countries is expected to reach almost 29% and 48% in women and men, respectively in years 1990-2020. However, in developing countries these data has been increased by 120% and 137% in women and men, respectively 10 . Hence, there is an urgent need to study the screening of anti-dyslipidemia properties of medicinal plants, which will be helpful in the treatment of diabetes,
CVD and CHD.
Passiflora foetida belongs to Passifloraceae, and is an exotic and fast-growing perennial, vine, occurring in west USA and extend to the Asian countries like India. The tribal people uses P. foetida for the treatment of various diseases namely diarrhea, asthma, intestinal tract, neurological disorders, throat, headache, ear infections, fever, hysteria and skin diseases. The phytoconstituents presents in P.
foetida are alkaloids, phenols, glycosides, flavonoids, cyanogenic compounds, passifloricins, polypeptides and alpha-pyrones [11] [12] [13] [14] [15] . The present study was planned to evaluate the ant-dyslipidemia activity of ethanol extract of leaves of P. foetida in dextrose induced diabetic rats.
Materials and Methods

Plant material
The fresh leaves of Passiflora foetida were collected from the area of botanical gareden, Acharya Nagarjuna University, Guntur. The plant material was identified and authenticated by a taxonomist in the University. The collected leaves were dried under shade and then ground into fine powder using laboratory mortar and pestle.
Preparation of plant extract
The powder (100 gm) of leaves was macerated in solvent containing 70% ethanol and 30% distilled water at room temperature for 72 h. This was then filtered using a filter paper and the filtrate was evaporated to dryness on water bath at 60 ºC and dried brown extract was kept in an air tight bottle until used.
Chemical used
All chemicals and drugs used were obtained commercially and were analytical grade. Dextrose was purchased from National Scientific Laboratory, PVT Ltd, Vijayawada.
Biosynthesis of Silver Nanoparticles
5% leaves extract, 10 mL of ammonia solution (1 M), and 10 mL of silver nitrate solution (10 mM) were mixed. The solution pH adjusts to the desired value by using sodium hydroxide or phosphoric acid solution and then was diluted until 100 mL with distilled water. The mixture was stirred for 4 h at 45°C. After centrifuging of silver nanoparticles solution for 10 min at 10000 rpm, silver nanoparticles were sedimented at the bottom of the conical tube. The supernatant phase was removed and silver nanoparticles were washed with 10 mL water for three times. After the washing, the residue was transferred to freeze dryer, and finally powder obtained 16, 17 .
Acute toxicity studies of the plant extract
The index of the acute toxicity was the LD 50 . In the initial phase, rats were divided into 3 groups of 6 rats each and were treated with P.
foetida extract at doses of 100 mg, 250 mg, 500 mg and 1000 mg/ kg body weight orally. The animals were observed for 24 h for signs of toxicity including death. Based on the results the next experiment was designed 18 .
Induction of experimental diabetes
Normal healthy male Wistar albino rats Dextrose was used to induce diabetes mellitus in male albino wistar rats. A freshly prepared dextrose solution was given orally at 6.6 gm/rat/5ml. After 15 days, rats with moderate diabetes having glycosuria and hyperglycemia were selected for the experiment.
Experimental design
A total of 54 rats were used in the present investigation. The animals were randomly divided into 9 groups and each group contain 6 rats.
The group I considered as normal group and no any treatment has given to them. The group II to group IX were administered dextrose, and further group II is considered as diabetic control group. Group III, Group IV and Group V were treated with extract at the dose of 100 mg/kg bw, 250 mg/kg bw and 500 mg/kg bw, respectively. Group VI were treated with glipizide (4 mg/kg bw); Group VII were treated with sitagliptin (0.14 mg/100gm bw); Group VIII were treated with vildagliptin(10 g/kg bw); and Group IX were treated with silver naoparticles(10 ml/kg bw). All treatments were given once daily for a period of 45 days.
At the end of the treatment, all rats were fasted for 12 hours and sacrificed by cervical decapitation. The blood was collected into heparinized tubes and plasma was separated by centrifugation and used for biochemical analysis.
Estimation of glucose
The collected serum samples of different study group were subjected to the serum glucose level estimation by enzymatic GOD-POD method.
Estimation of biochemical parameters
The biochemical parameters were determined on day 45 after the animals were sacrificed by cervical dislocation. Total cholesterol, triglycerides (TGL), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very low density lipoprotein (VLDL), were determined by the glucose oxidase method, using an autoanalyzer [19] [20] [21] [22] .
Statistical analysis
The results are expressed as mean ± SEM of six independent experiments. Statistical significance between the groups was evaluated by one-way analysis of variance (ANOVA) followed by Dunet's test. A P < 0.05 value was considered as statistically significant.
Results
The normal rats have the glucose level mean value134.50±5.75. The diabetic induced rats have the mean value of 428.67±25.97 which has significant variance when compared to normal rat mean. compared to diabetic rats (Table 1) . Among these, high dose is effective to reduce the LDL levels. The VLDL mean of normal rats were 26.57±.36 mg/dl. Diet induced diabetic rats have mean value of 45.82±.55. The VLDL of control group was significant increased compared to normal group rats. The VLDL of Glipizide, sitagliptin and vildagliptin treated rats significantly lowered when compared to diabetic rats. The extract treated rat decreases the VLDL level in rats, while the medium and high doses exhibited significant decrease in VLDL level. The diabetic rats treated with silver nanoparticles exhibited significant decreases in VLDL level compared to diabetic rats (Table 1) . Among these, high dose is effective to reduce the VLDL levels.
Discussions
Globally implies that the plant extract may be useful in reducing the complications of hyperlipidemia and hypercholesterolemia which often coexist in diabetics 32, 33 . The study also revealed that administration of the extract at various doses significantly lowered the serum LDL in dextrose-induced diabetic Wistar rats.
Conclusion
The study also showed that oral administration of all doses of the extract resulted to a significant decrease on the levels of lipid profile in dextrose-induced diabetes mellitus as well as improved hyperlipidemia associated with diabetes. In present study, all doses of P. foetida plant extract appeared to be effective and were comparable to the standard drugs (Glipizide, Sitagliptin and Vildagliptin). The result obtained from this work showed that the plant may be useful in the management of secondary complications of diabetes (dyslipidemia) associated with diabetes mellitus.
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